TY - JOUR
T1 - Optimizing the flavanone core toward new selective nitrogen-containing modulators of ABC transporters
AU - Ferreira, Ricardo J.
AU - Baptista, Rafael
AU - Moreno, Alexis
AU - Madeira, Patricia G.
AU - Khonkarn, Ruttiros
AU - Baubichon-Cortay, Hélène
AU - Dos Santos, Daniel Jva
AU - Falson, Pierre
AU - Ferreira, Maria José U.
N1 - Publisher Copyright:
© 2018 Newlands Press.
PY - 2018/4
Y1 - 2018/4
N2 - Aim: Naringenin (1), isolated in large amount from the aerial parts of Euphorbia pedroi, was chemically derivatized to yield 18 imine derivatives (2-19) and three alkylated derivatives through a Mannich-type reaction (20-22) that were tested as multidrug resistance (MDR) reversers in cancer cells. Results/methodology: While hydrazone (2-4) and azine (5-13) derivatives showed an improvement in their MDR reversal activities against the breast cancer resistance protein, carbohydrazides 14-19 revealed an enhancement in MDR reversal activity toward the multidrug resistance protein 1. Conclusion: The observed activities, together with pharmacophoric analysis and molecular docking studies, identified the spatial orientation of the substituents as a key structural feature toward a possible mechanism by which naringenin derivatives may reverse MDR in cancer.
AB - Aim: Naringenin (1), isolated in large amount from the aerial parts of Euphorbia pedroi, was chemically derivatized to yield 18 imine derivatives (2-19) and three alkylated derivatives through a Mannich-type reaction (20-22) that were tested as multidrug resistance (MDR) reversers in cancer cells. Results/methodology: While hydrazone (2-4) and azine (5-13) derivatives showed an improvement in their MDR reversal activities against the breast cancer resistance protein, carbohydrazides 14-19 revealed an enhancement in MDR reversal activity toward the multidrug resistance protein 1. Conclusion: The observed activities, together with pharmacophoric analysis and molecular docking studies, identified the spatial orientation of the substituents as a key structural feature toward a possible mechanism by which naringenin derivatives may reverse MDR in cancer.
KW - ABC transporters
KW - BCRP
KW - MRP1
KW - P-gp
KW - flavanone
KW - hydrazides
KW - hydrazones
KW - molecular docking
KW - multidrug resistance
KW - pharmacophore
UR - http://www.scopus.com/inward/record.url?scp=85046254616&partnerID=8YFLogxK
U2 - 10.4155/fmc-2017-0228
DO - 10.4155/fmc-2017-0228
M3 - Article
C2 - 29570361
AN - SCOPUS:85046254616
SN - 1756-8919
VL - 10
SP - 725
EP - 741
JO - Future Medicinal Chemistry
JF - Future Medicinal Chemistry
IS - 7
ER -